AzTrials
AzTrials

StrokeNCT07504848

Stroke Mobility and Caregiver Outcomes

An observational study of Stroke and Caregiver, run by Ondokuz Mayıs University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study was designed to determine the effect of functional mobility levels of stroke patients on caregiver burden, anxiety, and depression in their caregivers. Read more about this study

Who is it for?
Ages 18 to 75 yearsHealthy volunteers can take part
Conditions the study is for
Stroke, Caregiver
How many people
64 participants
Where
No sites listed yet
Study dates
2 Apr 2026to 15 Apr 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: This study includes adult individuals with a first-ever unilateral stroke and their primary caregivers. Stroke patients aged 18-75 years, at least 3 months post-stroke, with sufficient cognitive function (MMSE ≥24), and stable medical status are included. Caregivers are adults who have been living with the patient for at least one year and are the primary, non-professional caregivers.

Who may be able to join

  • Stroke Patients:
  • Diagnosed with stroke according to WHO criteria (≥20% disability rate documented in Adult Disability Health Board Report)
  • Having a family member or relative who provides care
  • First-ever and unilateral stroke
  • Willing to participate voluntarily
  • Aged between 18-75 years
Show all 16Show fewer
  • Post-stroke duration longer than 3 months
  • Stable vital signs
  • Scoring ≥24 on the Standardized Mini-Mental State Examination (SMMT) or the -Modified Mini-Mental State Examination for Illiterate Individuals (MMSE-E)
  • Able to understand and speak Turkish
  • Caregivers of Stroke Patients:
  • Willing to participate in the study
  • Living with the patient for at least 1 year
  • Being the primary (main responsible) caregiver and not receiving paid professional caregiving services
  • Aged 18 years or older
  • Scoring ≥24 on the Standardized Mini-Mental State Examination (SMMT) or MMSE-E

Who cannot join

  • Stroke Patients:
  • Presence of severe comorbid conditions
  • Unwillingness to participate
  • History of multiple strokes
  • Bilateral hemiplegia
  • Presence of major neurological, orthopedic, or rheumatologic disorders affecting the musculoskeletal system other than stroke
Show all 15Show fewer
  • Congenital anomalies or amputation causing disability
  • Uncontrolled arrhythmia, uncontrolled hypertension, or unstable cardiac conditions
  • Botulinum toxin injection within the last 6 months
  • Inability to establish cooperation
  • Presence of neglect, aphasia, or hemianopsia
  • Caregivers of Stroke Patients:
  • Unwillingness to participate
  • Living with the patient for less than 1 year
  • Presence of mental retardation, dementia, or severe psychotic disorders

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Seda Nur Kemer, PhD contact

+903623121919

sedanur.kemer@omu.edu.tr

About this study

Official title: The Effect of Mobility Level in Stroke Patients on Anxiety, Depression, and Caregiver Burden in Caregivers

This study was designed to determine the effect of functional mobility levels of stroke patients on caregiver burden, anxiety, and depression in their caregivers.

Conditions
Stroke, Caregiver
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07504848
Study groupRoleWhat they receive
Stroke PatientsNot described
CaregiversNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Brunnstrom Stages of Hemiplegic Recovery

    Measured: Baseline

  2. Beck Depression Inventory

    The Beck Depression Inventory (BDI) is scored between 0 and 63, where 0 indicates minimal or no depressive symptoms and 63 reflects severe depression; increasing scores correspond to greater severity of depressive symptomatology.

    Measured: Baseline

  3. Beck Anxiety Inventory

    Beck Anxiety Inventory (BAI) ranges from 0 to 63, with 0 indicating minimal anxiety and 63 indicating severe anxiety; higher scores represent increased severity of anxiety symptoms.

    Measured: Baseline

  4. Burden Interview

    Measured: Baseline

  5. Timed Up and Go Test

    Measured: Baseline

  6. Rivermead Mobility Index

    The Rivermead Mobility Index (RMI) ranges from 0 to 15. 0 indicates severe dependence with inability to perform basic mobility tasks. 15 indicates full independence in all assessed mobility activities. As the score increases, it reflects a progressive improvement in functional mobility, with greater independence in activities such as transfers, walking, and balance.

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Apr 2026
  2. Study start2 Apr 2026 (estimated)
  3. Primary completion15 Apr 2026 (estimated)
  4. Study completion15 Apr 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
64 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07504848
Sponsor's protocol ID
2025/105
Status last verified
Mar 2026
First submitted
26 Mar 2026
Last updated
6 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Stroke and Caregiver, run by Ondokuz Mayıs University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 16 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 6 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Seda Nur Kemer, PhD (+903623121919, sedanur.kemer@omu.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Brunnstrom Stages of Hemiplegic Recovery (time frame: Baseline). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Apr 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Stroke Mobility and Caregiver Outcomes (NCT07504848) | AzTrials